Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - tick-borne encephalitis virus (inactivated) neudoerfl - suspension for injection in pre-filled syringe - 0.25 millilitre(s) - encephalitis vaccines; encephalitis, tick borne, inactivated, whole virus - encephalitis vaccines - it is indicated for the active (prophylactic) immunization of children aged from 1 year to 15 years against tick-borne encephalitis (tbe).

Singapore - English - HSA (Health Sciences Authority)

princeton pharmacy (s) private limited - ophthalmology - for chemical splash on eyes and skin, removal of foreign particles, mucous secretions and fluorescein dye used in diagnosis.

Canada - English - Health Canada

princess auto ltd. - sodium hypochlorite - solution - 7.20% - sodium hypochlorite 7.20% - disinfectants (for agents used on object)

Australia - English - Department of Health (Therapeutic Goods Administration)

croma australia pty ltd - 47887 - synthetic-fluid tissue reconstructive material, anaesthetic - princess volume plus lidocaine is a sterile, biodegradable, viscoelastic, clear, transparent, isotonic and homogenized injectable gel implant. the device is intended for single use, it is non-active and without measuring function. a drug substance (lidocaine hydrochloride) is integrated into the device. the ancillary role of lidocaine hydrochloride is to reduce the pain associated with injections into the patient. the intended purpose of the device is to restore facial volume in order to correct moderate to severe midface volume deficit to treat signs of ageing.

Australia - English - Department of Health (Therapeutic Goods Administration)

croma australia pty ltd - 59131 - dermal tissue reconstructive material, microbe-derived - a sterile, biodegradable, viscoelastic, clear, colourless, isotonic and homogenized injectable gel implant. it consists of cross-linked hyaluronic acid, formulated to a concentration of 23 mg/ml in a physiologic buffer. princess filler is indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) and to increase lip volume.

Australia - English - Department of Health (Therapeutic Goods Administration)

croma australia pty ltd - 59131 - dermal tissue reconstructive material, microbe-derived - a sterile, viscoelastic, clear, colourless, transparent, isotonic, biodegradable and injectable gel composed of hyaluronate. princess rich is a viscoelastic solution to replenish the loss of hyaluronic acid due to ageing. it is designed to be injected into the superficial dermal tissue, preferably deeper, to improve tone and elasticity of the skin.

Australia - English - Department of Health (Therapeutic Goods Administration)

croma australia pty ltd - 59131 - dermal tissue reconstructive material, microbe-derived - a sterile, biodegradable, viscoelastic, clear, colourless, isotonic and homogenized, injectable gel. it consists of cross-linked hyaluronic acid formulated to a concentration of 23 mg/ ml in a physiologic buffer. princess volume is an injectable biodegradable gel to increase or restore volume of the face, remodel facial contours and correct deeper wrinkles and folds; it is indicated for injection into the deep dermis, subcutis or supraperiosteally.

United States - English - NLM (National Library of Medicine)

jiangsu jiangsu sincere pharmaceutical co., ltd - menthol  2.0%, methyl salicylate  2.0% - menthol                    topical analgesic methyl salicylate       topical analgesic for temporary relief of minor aches and pains of muscles and joints associated with: simple backache arthritis sprains strains bruises on wounds or damaged skin. with other external analgesic products at the same time. if you are allergic to any ingredients of this product. otherwise than as directed. avoid contact with the eyes, mucous membranes or rashes.

Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - attenuated canine distemper virus, strain ba5; attenuated canine adenovirus type 2, strain dk13; attenuated canine parvovirus, strain cag2; attenuated canine parainfluenza virus type 2, strain cgf 2004/75 - lyophilisate for suspension for injection - . - canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

averroes pharmaceuticals sdn. bhd. - furosemide -